About Dr. Mohtashem Samsam

Pain and migraine as well as the role of inflammation in neurological and psychiatric disorders.

Dr. Mohtashem Samsam is an Associate Professor of Medicine and a faculty at the Burnett School of Biomedical Sciences and College of Medicine (COM). He joined UCF in fall 2004. He is teaching anatomy, clinical neuroanatomy, and clinical neuroscience to undergraduate, graduate, and medical students. Dr. Samsam studied Medicine in English language program of Albert Szent-Gorgyi Medical University, in Szeged, Hungary (1991- 1996) and received his PhD in Neurosciences from Dep. of cell biology and pathology, Faculty of Medicine, University of Salamanca, Spain, in 2002. He did his post-doc studies in Developmental Neurobiology in Neurology University Clinic, Wuerzburg, Germany (1999- 2002).
Publishing several articles in headache and migraine during his MD and PhD studies he continued his post-doc studies examining the mechanism of neurodegeneration in animal models of inherited peripheral neuropathies and treatment of Charcot-Marie Tooth disorders using gene therapy and alteration of immune response. His research and scholarly activities are in migraine headaches and role of inflammation in neurological and psychiatric disorders.
Dr. Samsam is the Editor in Chief of Neuro-Open Journal, http://openventio.org/EditorialBoard/Neuro.html; and he is an editor of several journals including the DATA Sets International (Dataset Papers in Medicine), Psychiatry: http://www.hindawi.com/journals/dpis/editors/psychiatry/; editor in Austin Journal of Biomedical Engineering, http://austinpublishinggroup.com/biomedical-engineering/editorialboard.php; and an editor in Science Domain International, Archives of Current Research International: http://sciencedomain.org/journal/41/editorial-board-members.
He is the author of several book chapters and two textbooks.
Dr. Samsam has developed several courses at undergraduate and graduate levels at UCF, and as a member of curriculum planning committee he was heavily involved in the development of many of the medical courses for LCME accreditation in 2006-2007.
He received multiple awards during the past couple of years including the Golden Apple Excellence in Teaching Award & Professor of the Year, from UCF Premed-American Medical Student Association (AMSA) for 8 years in the row; the Excellence in Undergraduate Teaching Award, UCF, COM, 2009- 2010; the Scholarship of Teaching and Learning (SoTL) Award, UCF, COM, 2011-2012; the UCF Creed Award in Scholarship//med.ucf.edu/news/2012/05/dr-samsam-is-keeper-of-the-creed/, 2011-2012; and the Teaching Incentive Program (TIP) Award, UCF, COM, 2012- 2013.
Dr. Samsam led (2013-2015) a STEM internship program in partnership with and funded by the Career Source of Central Florida (CSCF) that is being facilitated by the UCF office of experiential learning. The program provides senior undergraduate students an opportunity to work and do research in COM labs for 6-month supported by the CSCF: //med.ucf.edu/news/2014/07/collaboration-creating-on-the-job-research-training-career-opportunities/
He is coordinating a similar program in UCF COM, the Florida Work Experience Program (FWEP), a UCF initiative coordinated and funded by the UCF Office of Experiential Learning to provide work and research experience to undergraduate students.
Recent Publications

  1. Samsam M, Ahangari R. Neuromodulation in the treatment of migraine: Progress in nerve stimulation. Neuro Open J. 2017; 3(1): 9-22. doi:10.17140/NOJ-3-122.
  2. Samsam M. Neuromodulation and nonpharmacological treatment of migraine. Editorial. Neuro Open J. 2016; 3(1): e5-e10. doi: 10.17140/NOJ-3-e006.
  3. Samsam M., Targeting calcitonin gene-related peptide and its receptor by monoclonal antibody, new developments in the treatment of migraine. Editorial,Neuro Open J. 2015; 2: e6-e10. http://dx.doi.org/10.17140/NOJ-2-e004.
  4. Samsam M., Drugs against calcitonin gene-related peptide and its receptor used in the treatment of migraine: What are the new progresses? Neuro Open J. 2015; 2: 79-91. http://dx.doi.org/10.17140/NOJ-2-117.
  5. Samsam M, Ahangari R, Naser SA. Pathophysiology of autism spectrum disorders: Revisiting gastrointestinal involvement and immune imbalance.World J Gastroenterol. 2014 Aug 7;20(29):9942-9951.
  6. Samsam M.:Functionally Oriented Regional Anatomy, Hayden McNeil, MI, USA, 2nd edition, 2013, ISBN: 978-0-7380-5685-2.
  7. Samsam M.:Regional Anatomy Lab, an e-book atlas of anatomy, Great River Technologies & Thieme, IA, USA, 1st edition, 2013, ISBN: 978-1-61549-278-7.
  8. Samsam M.Central nervous system drugs in treatment of neurological disorders, editorial, Cent Nerv Syst Agents Med Chem. 2012, 12:153-7.
  9. Samsam M.Central nervous system acting drugs in treatment of migraine headache, Cent Nerv Syst Agents Med Chem. 2012, 12:158-72
  10. Samsam M.Role of inflammation in neurological and psychiatric disorders, editorial, AIAA-MC, 2010, 3: 166-169.
  11. Samsam M.,Coveñas R., Ahangari R., Yajeya J. Neuropeptides and other chemical mediators, and the role of anti-inflammatory drugs in primary headaches, AIAA-MC, 2010, 3: 170- 188.
  12. Samsam M.,Coveñas R., Ahangari R., Yajeya J.: Major neuroanatomical and neurochemical substrates involved in primary headaches. In: Neuroanatomy Research Advances; chapter 1; Editors: CE Flynn and BR Callaghan; Nova Science Publishers; New York; 2009; pp1- 58; ISBN: 978-60741-610-4.
  13. Samsam M.,Coveñas R., Ahangari R., Yajeya J., Narváez JA.: Role of neuropeptides in migraine headaches, experimental and clinical data, Focus on Neuropeptide Research, chapter 11; Editor: R. Covenas; Transworld Research Network; India, released in 2008; ISBN: 978-81-7895-291-8.
  14. Samsam M.,Coveñas R., Ahangari R., Yajeya J. and Narváez JA.: Role of neuropeptides in migraine; where do they stand in the latest expert recommendations in migraine treatment? Drug Development Research, 2007, 68: 298- 314.
  15. Ruhlman T., Ahangari R., Devine A., Samsam M., Daniell H.: Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non-obese diabetic mice, Plant Biotechnol J., 2007, 5: 495- 510.